Table 3.

Changes of contents of IL-1β, TNF-α, MMP-1, MMP-3, and VEGF.

Outcome measures	Treatment group (n = 34)	Control group (n = 32)	P value
IL-1β (pg/mL)
Baseline	30.75 (16.31)	33.52 (16.34)	0.493†
Posttherapy	21.75 (10.61)	28.56 (15.69)	0.042†
TNF-α (pg/mL)
Baseline	27.66 (14.12)	20.60 (12.09)	0.204†
Posttherapy	32.43 (16.01)	27.07 (13.41)	0.043†
MMP-1 (pg/mL)
Baseline	2.85 (1.68)	3.69 (2.11)	0.076†
Posttherapy	2.38 (1.36)	3.39 (1.72)	0.010†
MMP-3 (pg/mL)
Baseline	141.40 (77.16)	160.11 (61.98)	0.283†
Posttherapy	120.77 (64.52)	152.18 (58.00)	0.042†
VEGF (pg/mL)
Baseline	87.43 (47.65)	109.84 (55.74)	0.083†
Posttherapy	66.27 (33.46)	91.18 (47.49)	0.016†

Values are represented as mean (SD). ^†P value by independent samples t test.